
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
InHealth Ventures is a London-based early-stage healthcare fund founded in 2016 by Ivan Bradbury. The firm focuses on addressing significant healthcare challenges by partnering with visionary founders to build companies that improve healthcare delivery and patient outcomes. InHealth Ventures operates as a subsidiary of InHealth Group, one of Europe's largest independent healthcare providers, which provides the firm with access to a vast network of clinical leaders and industry experts.
Currently, InHealth Ventures manages a portfolio of approximately 30 companies, with a strong emphasis on digital health solutions. The firm has established itself as a key player in the healthcare investment space, actively engaging in the North American, European, and Asian markets. Notable milestones include the successful exit of Kheiron Medical Technologies, which was acquired by DeepHealth in October 2024, showcasing the firm's ability to identify and nurture high-potential healthcare startups.
InHealth Ventures invests in early-stage healthcare companies, specifically targeting the pre-seed, seed, seed-plus, and Series A stages. The firm emphasizes its commitment to digital health, aiming to support companies that develop innovative solutions to improve healthcare delivery and patient outcomes. Their geographic focus spans North America, Europe, and Asia, allowing them to tap into diverse markets and healthcare challenges.
The investment strategy of InHealth Ventures includes assisting portfolio companies with product development, market entry, and international expansion. The firm seeks to partner with founders who are addressing critical healthcare issues and are committed to bending the healthcare cost curve. InHealth Ventures values innovative approaches that enhance access to healthcare services and improve overall patient outcomes.
InHealth Ventures has a diverse portfolio of approximately 30 companies, showcasing its commitment to various sectors within healthcare. Notable portfolio companies include:
This portfolio reflects InHealth Ventures' focus on digital health and innovative healthcare solutions, with a mix of companies at various stages of growth.
Ivan Bradbury - Founding Partner. Ivan has extensive experience in healthcare investment and has been instrumental in establishing InHealth Ventures. He has a strong background in identifying and supporting innovative healthcare startups.
Ben Evans - Managing Partner. Ben brings a wealth of experience in venture capital and healthcare, having led numerous successful investments in the sector.
Fiona Rooney - General Counsel. Fiona oversees legal matters for the firm, ensuring compliance and managing legal risks associated with investments.
Lavanya Bhamidipati - Partner. Lavanya focuses on sourcing and evaluating new investment opportunities, leveraging her expertise in healthcare technology.
Richard Bradford - Partner. Richard has a strong track record in healthcare investments and plays a key role in supporting portfolio companies post-investment.
To pitch to InHealth Ventures, founders should use the email address hello@inhealth.vc. A well-structured pitch deck is essential, including details on the business model, market opportunity, and team qualifications. Founders should expect a response within a few weeks, but timelines may vary based on the volume of inquiries.
Warm introductions are preferred, as they can facilitate a more favorable review process. Founders are encouraged to highlight any connections to InHealth Group or its network in their pitches.
In October 2024, InHealth Ventures participated in a Series D investment round for Suki AI, a company specializing in voice AI for clinicians. This investment highlights the firm's ongoing commitment to supporting innovative healthcare solutions.
In the same month, InHealth Ventures achieved a notable exit with Kheiron Medical Technologies, which was acquired by DeepHealth. This exit underscores the firm's ability to identify and nurture high-potential healthcare startups.
What are InHealth Ventures' investment criteria?
InHealth Ventures focuses on early-stage healthcare companies, particularly in the digital health sector. They invest at the pre-seed, seed, seed-plus, and Series A stages, looking for innovative solutions that address significant healthcare challenges.
How can founders apply or pitch to InHealth Ventures?
Founders can pitch to InHealth Ventures by reaching out via email at hello@inhealth.vc. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and team background.
What makes InHealth Ventures different from other healthcare investors?
InHealth Ventures benefits from its connection to InHealth Group, providing access to a vast network of clinical leaders and industry experts. This operational edge allows them to offer unique support to portfolio companies in product development and market entry.
What is the geographic scope of InHealth Ventures' investments?
The firm invests across North America, Europe, and Asia, allowing them to engage with a diverse range of healthcare challenges and opportunities.
What is the typical check size for investments made by InHealth Ventures?
While specific check sizes are not publicly disclosed, InHealth Ventures typically invests in early-stage rounds, which can range from hundreds of thousands to several million dollars, depending on the stage and needs of the company.
What kind of post-investment involvement does InHealth Ventures have?
InHealth Ventures actively supports its portfolio companies through product development, market entry strategies, and international expansion, leveraging its extensive network to enhance healthcare delivery and patient outcomes.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.